EU Panel Endorses First-of-Its-Kind Lung Cancer Drug
The first drug to target a KRAS mutation in non-small cell lung cancer (NSCLC) has been recommended for approval in Europe. At its November meeting, …
Home »
FDA OKs Adjuvant Atezolizumab for Early-Stage Lung Cancer
The US Food and Drug Administration has approved a new indication for the immunotherapy drug atezolizumab (Tecentriq) — the adjuvant treatment following …
NSCLC and Melanoma Lead Continuing Fall in US Cancer Death Rates
Cancer death rates in the United States continue to decline overall for many common cancers. This decline is particularly prounounced …
Neuronal Autoantibodies Tied to Cognitive Impairment in Lung Cancer
NEW YORK (Reuters Health) – More than one-third of lung cancer patients had neuronal autoantibodies that were associated with cognitive …